Peningkatan Kepatuhan Minum Obat Pasien Lupus Eritematosus Sistemik
DOI:
https://doi.org/10.59581/diagnosa-widyakarya.v1i2.210Keywords:
Systemic lupus erythematosus, medicine adherenceAbstract
Systemic Lupus Erythematosus (SLE) is an important systemic autoimmune disease. Women are ten times more at risk of developing LES than men. The etiology of SLE is not fully understood and the pathophysiology involves genetic, immunological, endocrine and environmental factors. SLE is a chronic disease with periods of remission and relapse, so it requires different management and a long time. Medication adherence is required so that treatment goals can be achieved. Medication adherence rates in people with lupus have been reported from various studies to be 31.7-45.9%. Non-adherence to treatment for SLE causes an increase in visits to the emergency department and also hospitalization. There are two kinds of factors that influence medication adherence, intentional non-adherence and non-intentional non-adherence. Efforts are needed to improve and increase medication adherence by considering these both factors.
References
Afzali P, Isaeian A, Sadeghi P, Moazzami B, Parvaneh N, Robatjazi M, et al. Complement Deficiency in Pediatric Onset Systemic Lupus Erythematosus. J Lab Physicians 2018;10:232-6. https://doi.org/10.4103/JLP.JLP_171_17
Albuquerque ES, Pinto LdS, Neto VLdM and Fragoso TS. Medication Adherence in Systemic Lupus Erythematosus During Brazilian COVID-19 Pandemic. Lupus. 2022; 0(0):1-7. https://doi.org/10.1177/09612033221074177
Angel A, Justiz VAA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. StatPearls Publishing. 2022.
Gottlieb, B.S. and Ilowite, N.T., 2006. Systemic Lupus Erythematosus in Children and Adolescents. American Academy of Pediatric, 27(9), pp.324–329.
Kasjmir, Y.I., Handono, K., Wijaya, L.K., Hamijoyo, L., Albar, Z., Kalim, H., Hermansyah and Kertia, N., 2011. Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik, Perhimpunan Reumatologi Indonesia.
Matusik P, Matusik PT and Stein PK. Heart Rate Variability in Patients with Systemic Lupus Erythematosus: A Systematic Review and Methodological Considerations. Sage Journals. 2018; 27(8). https://doi.org/10.1177/0961203318771502
Mina R, Scheven E, Ardoin S, Eberhard A, Punaro M, Ilowite N, et al. Consensus Treatment Plans for Induction Therapy of Newly-diagnosed Prolifetaive Lupus Nephritis in Juvenile Systemic Lupus Erythematosus. Arthritis Care Res. 2012;64(3):375-83.
Sheba SH, Djuhaeni H, Setiabudiawan B, Sunjaya DK, Mutyara K, Rinawan F. Kepatuhan Minum Obat Pada Pasien Lupus Eritematosus Sistemik di RSUP Dr. Hasan Sadikin Bandung. Majalah Kedokteran Bandung. 2018; 50(1): 21-28. http://dx.doi.org/10.15395/mkb.v50n1.1229
Tang PS, Lim SC, Arkachaisri T. Childhood-Onset Systemic Lupus Erythematosus: Southeas Asin Perspectives. J Clin Med. 2021; 10(559). https://doi.org/
3390/jcm10040559
Thakral, A. and Klein-Gitelman, M.S., 2016. An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus. Rheumatology and Therapy, 3(2), pp.209–219.
